Humana, Eli Lilly And A Major Mining Stock On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. FCX, adding that she likes the stock here in the mid-30s.

Freeport-McMoRan reported third-quarter revenue growth of 16.4% year-over-year to $5.82 billion, topping the consensus of $5.41 billion. Adjusted EPS of 39 cents exceeded the consensus estimate of 34 cents.

Stephen Weiss of Short Hills Capital Partners said Humana Inc. HUM was up around 2% on Monday, but it’s "down quite a bit."

Humana reported third-quarter adjusted EPS of $7.78 compared to $7.31 a year ago, beating the consensus of $7.16.

Don’t forget to check out our premarket coverage here

Joseph Terranova of Virtus Investment Partners named Eli Lilly and Company LLY as his final trade.

Eli Lilly reported better-than-expected financial results for the third quarter.

Price Action: Freeport-McMoRan shares gained 0.6% to close at $35.37, while Humana shares gained 2.2% to settle at $487.31on Monday. Eli Lilly gained 4.8% to close at $595.19 during Monday’s session.

Check This Out: Uber, D.R. Horton And 3 Stocks To Watch Heading Into Tuesday

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsMarketsMediaTrading IdeasBryn TalkingtonCNBCHalftime Report Final TradesJoseph TerranovaStephen Weiss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!